NIAID animation explains the ever-changing nature of influenza viruses.
Learn how immunizing a critical portion of a community protects most members of the community.
Volunteer for NIAID-funded clinical studies related to vaccines on ClinicalTrials.gov.
Vaccines provide safe, cost-effective, and efficient means of preventing illness, disability, and death from infectious diseases. NIAID conducts and supports research on new and improved vaccines and is a worldwide leader in the basic immunology research that underpins all vaccine research and development.
Overcoming Challenges in Staphylococcus aureus Vaccine Development - Meeting Summary, June 7, 2013 (PDF)
Two-Dose Rotavirus Vaccine Regimen Initiated During Newborn Period Prevents Rotavirus Diarrhea
Rabies Vaccine Protects Nonhuman Primates against Deadly Ebola Virus
Jordan Report: Accelerated Development of Vaccines 2012
Videocast: HHS Science Seminar for Media—Advances in Influenza Vaccine Technologies
NIAID Network of Vaccine and Treatment Evaluation Units (VTEUs)
Recent Successes in Developing an HIV Vaccine
NIAID Lab Developing Intranasal RSV Vaccines
NIAID Scientists Use Reverse Genetics to Develop Potential Dengue Vaccine
Flu Shots No More? NIAID Grantees Use New Skin Patches to Deliver Flu Vaccine in Mice
Research to Advance Vaccine Safety (R01 and R21)
Experimental Chikungunya Vaccine Induces Robust Antibody Response—Aug. 14, 2014
Media Availability: Vaccine Made from Complex of Two Malaria Proteins Protects Mice From Lethal Infection—June 23, 2014
Media Availability: Tdap Vaccination During Pregnancy Likely to Protect Newborns from Pertussis—May 3, 2014
Media Availability: International Scientists Convene to Chart Path, Measure Progress Toward Global Vaccine Research and Development—March 3, 2014
All Vaccine News Releases
News From NIAID-Supported Institutions
Last Updated August 14, 2014